Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Sodium ascorbate and menadione sodium bisulfite

EU orphan designation number: EU/3/14/1308   
Active ingredient: Sodium ascorbate and menadione sodium bisulfite
Indication: Treatment of autosomal dominant polycystic liver disease
Sponsor: MCA Regulatory Limited
195 Silver Street, Stansted, Essex CM24 78HB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/08/2014 Orphan designation EMA/OD/043/14 (2014)6114 of 22/08/2014
21/06/2016 Transfer of orphan designation EMA/OD/043/14/T/01 (2016)3852 of 16/06/2016